Arcadia Biosciences Inc (NAS:RKDA)
$ 4.14 -0.1 (-2.36%) Market Cap: 5.64 Mil Enterprise Value: -1.76 Mil PE Ratio: 0 PB Ratio: 0.48 GF Score: 61/100

Q1 2022 Arcadia Biosciences Inc Earnings Call Transcript

May 12, 2022 / 08:30PM GMT
Release Date Price: $34 (+2.10%)
Operator

Good afternoon, and welcome to Arcadia Biosciences First Quarter 2022 Earnings Conference Call. Today's presenters will be Stan Jacot, President, Chief Executive Officer; and Pam Haley, Chief Financial Officer of Arcadia. This call is being webcast, and you can refer to the company's press release at arcadiabio.com.

Before we start, we'd like to remind you that Arcadia will be making forward-looking statements on this call based on current expectations and currently available information. However, these statements are based on factors that include risks and uncertainties, and the company's actual performance and results may differ materially from those described or implied today. You can review the company's safe harbor language in its most recently filed 10-K.

With that, I'll turn the call over to Stan Jacot, CEO.

Stanley E. Jacot
Arcadia Biosciences, Inc. - President & CEO

Good afternoon, everyone, and thank you for joining us today for our 2022 first quarter conference call. Despite the fact that it has only been 6 weeks since we last

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot